Literature DB >> 36040711

Cannabidiol ameliorates the anxiogenic and compulsive-like behaviors induced by chronic consumption of a high-carbohydrate diet in male mice.

Anna Paula Marçal1, Nícia Soares1, Laila Asth1, Fabricio A Moreira1, Adaliene V M Ferreira2, Daniele C Aguiar3.   

Abstract

The excessive consumption of ultra-processed foods and the development of obesity has been associated with several comorbidities, including psychiatric disorders. Excess fat tissue promotes a low-intensity inflammatory state, mainly in the white tissue, which is essential in developing metabolic alterations and influences brain homeostasis. In this scenario, Cannabidiol (CBD), a compound from Cannabis sativa, has presented anxiolytic and anti-inflammatory effects in murine models. This study verified whether CBD treatment would ameliorate the compulsive-like and anxiety-like behaviors observed after mice's chronic consumption of a high-refined carbohydrate (HC) diet. BALB/c male mice received a control or HC diet for 12 weeks followed by vehicle and CBD (30 mg/Kg, i.p.) administration, and their behavior was evaluated in the Marble Burying test (MB) and Novel Suppressing Feeding test (NSF). The sub-chronic, but not acute, treatment with CBD attenuated the compulsive-like and anxiogenic-like behavior induced by the HC diet. Our data reinforced the harmful effects of the HC diet's chronic consumption on compulsive and anxious behaviors and the potential of CBD as a drug treatment for psychiatric disorders associated with obesity.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Anxiety; Cannabidiol; High-carbohydrate diet; Obesity; Obsessive-compulsive disorder

Year:  2022        PMID: 36040711     DOI: 10.1007/s11011-022-01071-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.655


  46 in total

1.  A standardization of the Novelty-Suppressed Feeding Test protocol in rats.

Authors:  Arantxa Blasco-Serra; Eva M González-Soler; Ana Cervera-Ferri; Vicent Teruel-Martí; Alfonso A Valverde-Navarro
Journal:  Neurosci Lett       Date:  2017-08-10       Impact factor: 3.046

2.  The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.

Authors:  Alline C Campos; Zaira Ortega; Javier Palazuelos; Manoela V Fogaça; Daniele C Aguiar; Javier Díaz-Alonso; Silvia Ortega-Gutiérrez; Henar Vázquez-Villa; Fabricio A Moreira; Manuel Guzmán; Ismael Galve-Roperh; Francisco S Guimarães
Journal:  Int J Neuropsychopharmacol       Date:  2013-01-09       Impact factor: 5.176

Review 3.  Cannabidiol (CBD) use in psychiatric disorders: A systematic review.

Authors:  Stefania Bonaccorso; Angelo Ricciardi; Caroline Zangani; Stefania Chiappini; Fabrizio Schifano
Journal:  Neurotoxicology       Date:  2019-08-11       Impact factor: 4.294

Review 4.  Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue.

Authors:  R Cancello; K Clément
Journal:  BJOG       Date:  2006-08-10       Impact factor: 6.531

5.  Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.

Authors:  Yane Costa Chaves; Karina Genaro; José Alexandre Crippa; Joice Maria da Cunha; Janaína Menezes Zanoveli
Journal:  Metab Brain Dis       Date:  2021-01-19       Impact factor: 3.584

6.  Dissecting the contribution of 5-HT1A auto- and heteroreceptors in sucrose overconsumption in mice.

Authors:  Kate Beecher; Joshua Wang; Fatemeh Chehrehasa; Ronan Depoortere; Mark A Varney; Adrian Newman-Tancredi; Selena E Bartlett; Arnauld Belmer
Journal:  Biomed Pharmacother       Date:  2022-02-11       Impact factor: 6.529

Review 7.  Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.

Authors:  Alline Cristina Campos; Fabricio Araújo Moreira; Felipe Villela Gomes; Elaine Aparecida Del Bel; Francisco Silveira Guimarães
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 8.  The impact of obesity and hypercaloric diet consumption on anxiety and emotional behavior across the lifespan.

Authors:  Kathryn D Baker; Amy Loughman; Sarah J Spencer; Amy C Reichelt
Journal:  Neurosci Biobehav Rev       Date:  2017-10-18       Impact factor: 8.989

Review 9.  Cannabidiol, neuroprotection and neuropsychiatric disorders.

Authors:  Alline C Campos; Manoela V Fogaça; Andreza B Sonego; Francisco S Guimarães
Journal:  Pharmacol Res       Date:  2016-02-01       Impact factor: 7.658

Review 10.  Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.

Authors:  Alline C Campos; Manoela V Fogaça; Franciele F Scarante; Sâmia R L Joca; Amanda J Sales; Felipe V Gomes; Andreza B Sonego; Naielly S Rodrigues; Ismael Galve-Roperh; Francisco S Guimarães
Journal:  Front Pharmacol       Date:  2017-05-23       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.